The overmentioned PI3K was shown to stabilize N-Myc in mouse models for pediatric neural cancers [96]; PI3K overactivation has been reported in both neuroblastoma samples and cell lines, although its mutations are quite rare. Here, MYCN is linked to neuroblastoma.